Guidance Documents

This guidance explains that long COVID can be a disability under Titles II and III of the Americans with Disabilities Act, Section 504 of the Rehabilitation Act of 1973, and Section 1557 of the Patient Protection and Affordable Care Act.  This guidance also provides resources for additional information and best practices.

This guidance document addresses issues pertaining to an individual practitioner’s use of their home address as a principal place of business or professional practice and the home address becoming controlled premises subject to unannounced inspections and administrative warrants under existing Drug Enforcement Administration (DEA) regulations

Red more to find out what is considered a disaster and tips on how to prepare as an FFL.

The purpose of this open letter is to advise you that the Louisiana Lifetime Concealed Handgun Permit (Lifetime Permit) meets the requirements as an alternative to the National Instant Criminal Background Check System (NICS) check only during the five-year period beginning on the date of issuance of the Lifetime Permit.

This document (issued jointly with ED-OCR) is an updated resource for students and families on confronting COVID-19 related bullying and harassment against Asian American and Pacific Islander (AAPI) students. It recognizes that in schools around the country, AAPI students have reported bullying and harassment by classmates because of their race or national origin, including their ethnicity, ancestry, and language. The resource is available in twelve AAPI languages.

The purpose of this Open Letter is to advise you of an important change to the procedure you must follow to comply with the Brady Handgun Violence Prevention Act (Brady Law), 18 U.S.C. § 922(t), when transferring a firearm to an unlicensed person.

This guidance summarizes the Department’s policies on how it administers its Federal grants in compliance with Executive Order 13798, the Attorney General’s Memorandum “Federal Law Protections for Religious Liberty,” and OMB Memorandum M-20-09.

This guidance document answers the question: “If electronic prescriptions for controlled substances be sent by e-mail.”

Question and Answer addressing if a Researcher registrant should complete a DEA Form 222 when participating in double-blind studies in which the exact quantity of schedule I or II controlled substances received is unknown.

Q&A answering whether a physician transport controlled substances and administer controlled substances at the patient’s home residence (the so-called “black bag exception”).

This presentation on fireworks provides an overview of the classification of explosive materials and exemptions under Part 555, storage, identifying appropriate Tables of Distances and determining if a variance to deviate from the regulations might be needed.